These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7259582

  • 21. [Comparison of the efficacy of propafenone and hydroquinidine in stabilized extrasystolic ventricular arrhythmia by means of dynamic electrocardiographic Holter monitoring].
    Rizzon P, De Toma L, Mangini SG, Lagioia R, Scrutinio D, Accettura D, De Nicolò M.
    G Ital Cardiol; 1984 May; 14(5):345-51. PubMed ID: 6205924
    [Abstract] [Full Text] [Related]

  • 22. Propafenone for the treatment of refractory complex ventricular ectopic activity.
    Hammill SC, Sorenson PB, Wood DL, Sugrue DD, Osborn MJ, Gersh BJ, Holmes DR.
    Mayo Clin Proc; 1986 Feb; 61(2):98-103. PubMed ID: 3945115
    [Abstract] [Full Text] [Related]

  • 23. [Relation between plasma levels of propafenone and its clinical efficacy in the treatment of patients with stabilized ventricular ectopic beats].
    Naccarella F, Marchesini A, Palmieri M, Ambrosioni E, Bracchetti D.
    Minerva Cardioangiol; 1984 Apr; 32(4):221-6. PubMed ID: 6462472
    [No Abstract] [Full Text] [Related]

  • 24. [Action of propafenon in experimentally digitalis glycoside-induced arrhythmia].
    Germiniani H, Branco Germiniani CD, Iark FB, do Pillar MD.
    Arq Bras Cardiol; 1979 Jul; 33(1):77-83. PubMed ID: 526179
    [No Abstract] [Full Text] [Related]

  • 25. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias].
    Fiol M, Palma JL, Bayés de Luna A, Aza V, Sadurní J.
    Rev Esp Cardiol; 1984 Jul; 37(3):196-200. PubMed ID: 6505351
    [No Abstract] [Full Text] [Related]

  • 26. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
    Palmieri M, Capucci A, Lombardi G, Naccarella F, Bomba E, Bracchetti D.
    G Ital Cardiol; 1984 May; 14(5):357-9. PubMed ID: 6468817
    [Abstract] [Full Text] [Related]

  • 27. [Electrophysiologic and anti-arrhythmia properties of propafenone deducible from experimental studies in vitro].
    Ledda F, Mantelli L.
    G Ital Cardiol; 1984 Apr; 14(4):279-84. PubMed ID: 6329868
    [Abstract] [Full Text] [Related]

  • 28. [Propafenone: a new anti-arrhythmic drug for treatment of ectopic ventricular beats].
    Molinis G, Valente M, Tuniz D, Maisano G.
    Cardiologia; 1982 Apr; 27(2):211-7. PubMed ID: 6892412
    [No Abstract] [Full Text] [Related]

  • 29. [Use of propafenon in post-operative period of cardiac surgery].
    Fontes RD, Puig LB, Pomerantzeff PA, Grinberg M, Teófilo Júnior S, Alliney HR, Camargo Júnior PA, Santos FA, Bittencourt D, Verginelli G, Zerbini EJ.
    Arq Bras Cardiol; 1979 Nov; 33(5):395-7. PubMed ID: 550775
    [No Abstract] [Full Text] [Related]

  • 30. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N, Terry L, Murphy ML, Thompson CH, Doherty JE, Sakhaii M, Dinh H.
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [Abstract] [Full Text] [Related]

  • 31. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E, Vitali A, Cucchi GF.
    Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
    [No Abstract] [Full Text] [Related]

  • 32. [Action of propafenon in experimental arrhythmias induced by coronary artery ligation].
    Cerci MS, Bürger JC de M, Germiniani C de LB, Germiniani H.
    Arq Bras Cardiol; 1979 Aug; 33(2):161-71. PubMed ID: 539927
    [No Abstract] [Full Text] [Related]

  • 33. [Changes in the mechanical action of the isolated guinea pig heart induced by doses of propafenon capable of affecting the electrocardiogram].
    Tucci PJ, Cicogna AC, Spadaro J.
    Arq Bras Cardiol; 1979 Sep; 33(3):229-32. PubMed ID: 543812
    [No Abstract] [Full Text] [Related]

  • 34. A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes.
    Salerno DM, Granrud G, Sharkey P, Asinger R, Hodges M.
    Am J Cardiol; 1984 Jan 01; 53(1):77-83. PubMed ID: 6362387
    [Abstract] [Full Text] [Related]

  • 35. [Serum concentration and AV-conduction time in oral treatment with propafenone during a several-days period (author's transl)].
    Meyer-Estorf G, Keller K, Beck OA, Hochrein H.
    Z Kardiol; 1980 Jun 01; 69(6):417-20. PubMed ID: 6160684
    [Abstract] [Full Text] [Related]

  • 36. [Study of the electrophysiologic effects of propafenon in patients with cardiac pre-excitation].
    Disertori M, Vergara G, Inama G, Guarnerio M, Dal Forno P, Furlanello F.
    Boll Soc Ital Cardiol; 1981 Jun 01; 26(11):1725-8. PubMed ID: 7349232
    [No Abstract] [Full Text] [Related]

  • 37. [Propafenon in the prevention of ventricular extrasystole of Chagas etiology related to physical effort. Evaluation by cycloergometry].
    Porto CC, Guimarães E, Rosa J, Rassi A.
    Arq Bras Cardiol; 1982 Aug 01; 39(2):129-33. PubMed ID: 6189470
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL.
    Minerva Cardioangiol; 1995 Oct 01; 43(10):449-57. PubMed ID: 8819814
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.